| Serial Number | 77388974 |
| Word Mark | THERAMAP |
| Filing Date | Tuesday, February 5, 2008 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, January 19, 2010 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Advisory services relating to diagnostic preparations and products, namely, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for psychiatric disorders, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of diseases and disorders of the central nervous system, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of Psychiatric diseases and disorders, and consulting and advisory services relating to the provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; advisory services relating to diagnostic apparatus and diagnostic instruments, namely, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for psychiatric disorders, relating to apparatus and instruments used in the prediction of the response of individuals to pharmaceutical products and treatment for diseases and disorders of the central nervous system, relating to apparatus and instruments used in the prediction of the response of individuals to pharmaceutical products and treatment for psychiatric diseases and disorders, consulting and advisory services relating to the development, testing and efficacy, of apparatus and diagnostic instruments for the treatment of diseases and disorders of the central nervous system, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of psychiatric diseases and disorders, in connection with assays or assay kits for use in the collection and testing of DNA, RNA and bodily tissues, and in connection with assay kits (which may contain reagents) for use in the collection of DNA, RNA and bodily tissues; design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments, for disorders of the central nervous system; design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments, for psychiatric disorders; design and control of pharmacogenetic diagnostic tests for disorders and diseases of the central nervous system; design and control of pharmacogenetic diagnostic tests for psychiatric diseases and disorders; design and control of pharmacogenetic tests, including the devising, compiling and testing of algorithms and mathematical systems for predicting response to a pharmaceutical product based on individual genetic profile; scientific research related to pharmacogenetics; research and advisory services relating to pharmaceuticals |
| Goods and Services | Medical diagnostic services; diagnostic testing relating to the human body, namely, diagnostic testing and analysis of samples, in order to predict response of individuals to pharmaceutical products and treatments for disorders of the central nervous system, diagnostic testing and analysis of samples in order to predict response of individuals to pharmaceutical products and treatments for psychiatric disorders, diagnostic testing and analysis of samples in order to confirm diagnosis of diseases and disorders of the central nervous system, and diagnostic testing and analysis of samples in order to confirm diagnosis of Psychiatric diseases and disorders; clinical services, namely, the analysis of samples of DNA, RNA and bodily tissues in order to prescribe the pharmaceutical product or treatment best suited to the patient (i.e. the pharmaceutical product likely to have the most beneficial effect and/or the one with fewest or least severe side effects), the taking of samples of bodily tissues for analysis in connection with the prescription of pharmaceuticals, or other medical treatment, and medical and scientific research in the nature of conducting clinical trials; compilation of medical reports, relating to prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system; compilation of medical reports, relating to confirmation of diagnosis of diseases and disorders of the body, and prescription of most efficient and efficacious pharmaceutical product or method for treatment thereof; compilation of medical reports, namely, a resource of phenotypic and genotypic data relating to diseases and disorders of the central nervous system and psychiatric diseases and disorders; conducting of medical examinations for diagnosis of treatments; testing and profiling for medical purposes; computer aided diagnostic testing services relating to the human body |
| Pseudo Mark | THERA GENETICS MAP |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 8, 2008 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 8, 2008 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TheraGenetics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | London SE58AF GB |
| Event Date | Event Description |
| Tuesday, January 19, 2010 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Tuesday, January 19, 2010 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, June 23, 2009 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Tuesday, June 23, 2009 | INQUIRY TO SUSPENSION E-MAILED |
| Tuesday, June 23, 2009 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, June 23, 2009 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
| Tuesday, December 23, 2008 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 23, 2008 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 23, 2008 | SUSPENSION LETTER WRITTEN |
| Tuesday, December 23, 2008 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, December 23, 2008 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 23, 2008 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 23, 2008 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, December 11, 2008 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 11, 2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 9, 2008 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 24, 2008 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 24, 2008 | NON-FINAL ACTION E-MAILED |
| Monday, November 24, 2008 | NON-FINAL ACTION WRITTEN |
| Friday, November 7, 2008 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 7, 2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 5, 2008 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 6, 2008 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, May 5, 2008 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, May 5, 2008 | NON-FINAL ACTION E-MAILED |
| Monday, May 5, 2008 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 30, 2008 | ASSIGNED TO EXAMINER |
| Tuesday, April 29, 2008 | ASSIGNED TO EXAMINER |
| Wednesday, March 19, 2008 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Thursday, March 13, 2008 | ASSIGNED TO LIE |
| Friday, February 15, 2008 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Saturday, February 9, 2008 | NOTICE OF PSEUDO MARK MAILED |
| Friday, February 8, 2008 | NEW APPLICATION ENTERED IN TRAM |